Data is not available at this time.
Medical Properties Trust, Inc. (MPT) is a leading global real estate investment trust (REIT) specializing in net-leased hospital facilities. The company operates across nine countries, owning 431 facilities with approximately 43,000 licensed beds, making it one of the largest hospital property owners worldwide. MPT’s core revenue model revolves around long-term triple-net leases, where tenants cover property expenses, providing stable cash flows. The REIT primarily serves healthcare operators, enabling them to monetize real estate assets for operational upgrades and expansions. MPT’s diversified portfolio spans acute care, behavioral health, and rehabilitation hospitals, mitigating regional and operator-specific risks. The company’s market position is strengthened by its expertise in structuring sale-leaseback transactions and financing solutions tailored to healthcare providers. Despite macroeconomic headwinds, MPT maintains a competitive edge through its scale, geographic diversification, and deep industry relationships. The REIT’s focus on mission-critical healthcare assets aligns with long-term demographic trends, supporting demand resilience.
MPT reported revenue of $995.5 million, reflecting its large-scale leasing operations. However, the company posted a net loss of -$2.41 billion, driven by non-cash impairments and elevated interest expenses. Operating cash flow stood at $245.5 million, indicating underlying lease income stability. Capital expenditures totaled -$261.7 million, primarily for property acquisitions and upgrades. The diluted EPS of -$4.02 underscores near-term profitability challenges amid sector-wide pressures.
MPT’s earnings power is underpinned by long-term lease agreements, though recent impairments have strained profitability. The REIT’s capital efficiency is moderated by high leverage, with total debt at $8.93 billion against a market cap of $2.73 billion. Operating cash flow coverage remains adequate but requires careful monitoring given interest rate sensitivity and tenant credit risks.
MPT’s balance sheet shows $332.3 million in cash against $8.93 billion in total debt, highlighting significant leverage. The REIT’s financial health is pressured by rising interest costs and tenant liquidity issues, though its asset base provides collateral flexibility. Debt maturities and refinancing risks remain key concerns in the current rate environment.
Growth has slowed due to asset sales and reduced acquisition activity, though international exposure offers diversification. MPT maintains a dividend yield of approximately 0.39 per share, but sustainability depends on stabilizing core FFO and managing leverage. The REIT’s historical growth via sale-leasebacks faces headwinds from operator financial stress.
Trading at a depressed market cap of $2.73 billion, MPT reflects investor skepticism around tenant defaults and balance sheet risks. The REIT’s beta of 1.459 indicates high volatility relative to the market, pricing in sector-specific uncertainties. Valuation metrics remain contingent on resolving operator credit challenges.
MPT’s scale and healthcare focus provide structural advantages, but near-term outlook is cautious. Success hinges on stabilizing tenant operations, executing asset sales, and deleveraging. Long-term demand for healthcare real estate supports recovery potential, though execution risks persist.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |